The oversubscribed fund signals strong LP appetite for European deep‑tech and gives startups unprecedented early‑stage capital, accelerating commercialization of research‑driven innovations.
The European deep‑tech landscape has entered a period of sustained growth, driven by a confluence of academic excellence, patient capital, and coordinated policy support such as France’s Tibi 2 programme. Public investors like Bpifrance are increasingly allocating sizable allocations to venture funds that specialize in high‑risk, high‑reward technologies, creating a fertile financing environment that contrasts with the more volatile US market. Elaia’s successful €134 million close for its third deep‑tech seed fund exemplifies this trend, demonstrating that limited partners are willing to commit capital well beyond initial targets to capture the upside of breakthrough science.
Elaia’s model hinges on close collaboration with premier research institutions, notably Université PSL and Inria, which supplies a pipeline of spin‑outs before they reach the open market. By writing seed tickets as small as €300,000 and focusing on three strategic pillars—computing (including generative AI, quantum and cybersecurity), future of industry (energy, climate tech, advanced materials) and life sciences—the fund can nurture nascent ventures from proof‑of‑concept to market‑ready stages. Past successes such as AI‑driven drug‑discovery platform Aqemia, quantum startup Alice & Bob, and biotech Mablink illustrate the tangible outcomes of this academically‑anchored approach.
With DTS3 and the concurrently raised Digital Venture Fund, Elaia is positioning itself as a full‑stack investor capable of supporting companies from pre‑seed through growth rounds. This continuity reduces fundraising friction for founders and creates a competitive advantage in attracting top talent. As the fund’s €850 million‑plus AUM places Elaia among Europe’s elite early‑stage investors, its strategy may spur other VCs to deepen university partnerships, amplifying the continent’s capacity to translate research breakthroughs into global market leaders.
Paris‑based venture capital firm Elaia announced the final close of its third deep‑tech seed fund (DTS3) at €134 million, surpassing its €120 million target. Backed by Bpifrance and Université PSL, the fund will invest in early‑stage B2B deep‑tech startups across AI, quantum, cybersecurity, energy, climate tech and life sciences.
Comments
Want to join the conversation?
Loading comments...